Intravenous Administration of Autoserum-cultured Autologous Mesenchymal Stem Cells in Ischemic Stroke: A Single Center, Randomized, Open Label, Prospective, Phase 3 Study
Phase of Trial: Phase III
Latest Information Update: 28 Apr 2017
At a glance
- Drugs Mesenchymal stem cell therapy (Primary)
- Indications Stroke
- Focus Registrational; Therapeutic Use
- Acronyms STARTING-2
- Sponsors Pharmicell
- 24 Apr 2017 Planned End Date changed from 1 Feb 2016 to 1 Dec 2017.
- 24 Apr 2017 Planned primary completion date changed from 1 Nov 2015 to 1 Dec 2017.
- 20 Feb 2016 New trial record